Dietary Supplementations and Depression

References

• Rao AL, Hong ES. Understanding depression and suicide in college athletes: emerging concepts and future directions. Br J Sports Med. 2016;50(3):136–137. doi:10.1136/bjsports-2015-095658
   PubMed Web of Science ®Google Scholar
• Metrics GH. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990 – 2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2019;1990–2017. DOI:10.1016/S0140-6736(18)32279-7
   PubMed Web of Science ®Google Scholar
• Koo SK. Depression status in Korea. Osong Public Heal Res Perspect. 2018;9(4):141–142. doi:10.24171/j.phrp.2018.9.4.01
   PubMedGoogle Scholar
• World Health Organization. Depression; 2021. Available from: https://www.who.int/news-room/fact-sheets/detail/depression. Accessed April 9, 2022.
   Google Scholar
• Nikam YL, Choudhary SE, Gochade M. Depression in teens: a overview. Int J Recent Adv Multidisciplin Topics. 2021;2(8):46–47.
   Google Scholar
• Yamasaki K, Hasegawa T, Takeda M. Serum level of soluble interleukin 6 receptor is a useful biomarker for identification of treatment-resistant major depressive disorder. Neuropsychopharmacol Rep. 2020;40(2):130–137. doi:10.1002/npr2.12100
   PubMed Web of Science ®Google Scholar
• Klengel T, Binder EB. Gene-environment interactions in major depressive disorder. Can J Psychiatry. 2013;58(2):76–83. doi:10.1177/070674371305800203
   PubMed Web of Science ®Google Scholar
• Muneer A. Mixed states in bipolar disorder: etiology, pathogenesis and treatment. Chonnam Med J. 2017;53(1):1. doi:10.4068/cmj.2017.53.1.1
   PubMedGoogle Scholar
• Patel R, Rose G. Persistent Depressive Disorder. StatPearls Publishing LLC; 2021.
   Google Scholar
• Hidaka BH. Depression as a disease of modernity: explanations for increasing prevalence. J Affect Disord. 2012;140(3):205–214. doi:10.1016/j.jad.2011.12.036
   PubMed Web of Science ®Google Scholar
• Khushboo BS. Antidepressants: mechanism of action, toxicity and possible amelioration. J Appl Biotechnol Bioeng.2017;3(5). doi:10.15406/jabb.2017.03.00082
   Google Scholar
• Gartlehner G, Wagner G, Matyas N, et al. Pharmacological and non-pharmacological treatments for major depressive disorder: review of systematic reviews. BMJ Open. 2017;7(6):1–13. doi:10.1136/bmjopen-2016-014912
   Web of Science ®Google Scholar
• Cipriani A, Furukawa TA, Salanti G, et al. Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis. Lancet. 2018;391(10128):1357–1366. doi:10.1016/S0140-6736(17)32802-7
   PubMed Web of Science ®Google Scholar
• Forneris CA, Nussbaumer-Streit B, Morgan LC, et al. Psychological therapies for preventing seasonal affective disorder. Cochrane Database Syst Rev. 2019;2019(5). doi:10.1002/14651858.CD011270.pub3
   Web of Science ®Google Scholar
• Haller H, Anheyer D, Cramer H, Dobos G. Complementary therapies for clinical depression: an overview of systematic reviews. BMJ Open. 2019;9(8):1–15. doi:10.1136/bmjopen-2018-028527
   PubMed Web of Science ®Google Scholar
• FDA. What you need to know about dietary supplements; 2017. Available from: https://www.fda.gov/food/buy-store-serve-safe-food/what-you-need-know-about-dietary-supplements. Accessed May 3, 2022.
   Google Scholar
• Kazemi A, Noorbala AA, Azam K, Eskandari MH, Djafarian K. Effect of probiotic and prebiotic vs placebo on psychological outcomes in patients with major depressive disorder: a randomized clinical trial. Clin Nutr. 2018;1–7. doi:10.1016/j.clnu.2018.04.010
   Web of Science ®Google Scholar
• Hoffmann K, Emons B, Brunnhuber S, Karaca S, Juckel G. The role of dietary supplements in depression and anxiety-a narrative review. Pharmacopsychiatry. 2019;52(6):261–279. doi:10.1055/a-0942-1875
   PubMed Web of Science ®Google Scholar
• Syed EU, Wasay M, Awan S. Vitamin B12 supplementation in treating major depressive disorder: a randomized controlled trial. Open Neurol J. 2013;7(1):44–48. doi:10.2174/1874205x01307010044
   PubMedGoogle Scholar
• Wang J, Um P, Dickerman BA, Liu J. Zinc, magnesium, selenium and depression: a review of the evidence, potential mechanisms and implications. Nutrients. 2018;10(5):1–19. doi:10.3390/nu10050584
   Web of Science ®Google Scholar
• Ng QX, Koh SSH, Chan HW, Ho CYX. Clinical use of curcumin in depression: a meta-analysis. J Am Med Dir Assoc. 2017;18(6):503–508. doi:10.1016/j.jamda.2016.12.071
   PubMed Web of Science ®Google Scholar
• McNamara RK, Jandacek R, Rider T, et al. Effects of fish oil supplementation on prefrontal metabolite concentrations in adolescents with major depressive disorder: a preliminary 1H MRS study. Nutr Neurosci. 2016;19(4):145–155. doi:10.1179/1476830514Y.0000000135
   PubMed Web of Science ®Google Scholar
• Nishi D, Su KP, Usuda K, et al. Differences between Japan and Taiwan in the treatment of pregnant women with depressive symptoms by omega-3 fatty acids: an open-label pilot study. Nutr Neurosci. 2019;22(1):63–71. doi:10.1080/1028415X.2017.1354540
   PubMed Web of Science ®Google Scholar
• Hsu MC, Tung CY, Chen HE. Omega-3 polyunsaturated fatty acid supplementation in prevention and treatment of maternal depression: putative mechanism and recommendation. J Affect Disord. 2018;238:47–61. doi:10.1016/j.jad.2018.05.018
   PubMed Web of Science ®Google Scholar
• Wani AL, Bhat SA, Ara A. Omega-3 fatty acids and the treatment of depression: a review of scientific evidence. Integr Med Res. 2015;4:1–10. doi:10.1016/j.imr.2015.07.003
   PubMedGoogle Scholar
• Park Y, Park YS, Kim SH, Oh DH, Park YC. Supplementation of n-3 polyunsaturated fatty acids for major depressive disorder: a randomized, double-blind, 12-week, placebo-controlled trial in Korea. Ann Nutr Metab. 2015;66(2–3):141–148. doi:10.1159/000377640
   PubMed Web of Science ®Google Scholar
• Ravi S, Khalili H, Abbasian L, Arbabi M, Ghaeli P. Effect of omega-3 fatty acids on depressive symptoms in HIV-positive individuals: a randomized, placebo-controlled clinical trial. Ann Pharmacother. 2016;50(10):797–807. doi:10.1177/1060028016656017
   PubMed Web of Science ®Google Scholar
• Lotrich FE, Sears B, McNamara RK. Elevated ratio of arachidonic acid to long-chain omega-3 fatty acids predicts depression development following interferon-alpha treatment: relationship with interleukin-6. Brain Behav Immun. 2013;31:48–53. doi:10.1016/j.bbi.2012.08.007
   PubMed Web of Science ®Google Scholar
• Ginty AT, Conklin SM. Short-term supplementation of acute long-chain omega-3 polyunsaturated fatty acids may alter depression status and decrease symptomology among young adults with depression: a preliminary randomized and placebo controlled trial. Psychiatry Res. 2015;229(1–2):485–489. doi:10.1016/j.psychres.2015.05.072
   PubMed Web of Science ®Google Scholar
• Jamilian M, Shojaei A, Samimi M, et al. The effects of omega-3 and vitamin E co-supplementation on parameters of mental health and gene expression related to insulin and inflammation in subjects with polycystic ovary syndrome. J Affect Disord. 2018;229:41–47. doi:10.1016/j.jad.2017.12.049
   PubMed Web of Science ®Google Scholar
• Raygan F, Ostadmohammadi V, Bahmani F, Asemi Z. The effects of vitamin D and probiotic co-supplementation on mental health parameters and metabolic status in type 2 diabetic patients with coronary heart disease: a randomized, double-blind, placebo-controlled trial. Prog Neuro Psychopharmacol Biol Psychiatry. 2018;84:50–55. doi:10.1016/j.pnpbp.2018.02.007
   PubMed Web of Science ®Google Scholar
• Yosaee S, Soltani S, Esteghamati A, et al. Effects of zinc, vitamin D and their co-supplementation on mood, serum cortisol, and brain-derived neurotrophic factor in patients with obesity and mild to moderate depressive symptoms: a 12-week, 2 × 2 factorial design, double-blind, randomized, placebo-. Nutrition. 2019;71:110601. doi:10.1016/j.nut.2019.110601
   PubMed Web of Science ®Google Scholar
• Hansen JP, Pareek M, Hvolby A, et al. Vitamin D3 supplementation and treatment outcomes in patients with depression (D3 ‑ vit ‑ dep). BMC Res Notes. 2019;12:1–6. doi:10.1186/s13104-019-4218-z
   PubMed Web of Science ®Google Scholar
• Bivona G, Agnello L, Ciaccio M. The immunological implication of the new vitamin D metabolism. Cent Eur J Immunol. 2018;43(3):331–334. doi:10.5114/ceji.2018.80053
   PubMed Web of Science ®Google Scholar
• Spedding S. Vitamin D and depression: a systematic review and meta-analysis comparing studies with and without biological flaws. Nutrients. 2014;6:1501–1518. doi:10.3390/nu6041501
   PubMed Web of Science ®Google Scholar
• Jhee JH, Kim H, Park S, et al. Vitamin D deficiency is significantly associated with depression in patients with chronic kidney disease. Cytokine. 2017;103:1–13. doi:10.1371/journal.pone.0171009
   PubMed Web of Science ®Google Scholar
• Berridge MJ. Vitamin D and depression: cellular and regulatory mechanisms. Pharmacol Rev. 2017;69:80–92. doi:10.1124/pr.116.013227
   PubMed Web of Science ®Google Scholar
• Beilfuss J, Berg V, Sneve M, Jorde R, Kamycheva E. Effects of a 1-year supplementation with cholecalciferol on interleukin-6, tumor necrosis factor-alpha and insulin resistance in overweight and obese subjects. Cytokine. 2012;60(3):870–874. doi:10.1016/j.cyto.2012.07.032
   PubMed Web of Science ®Google Scholar
• Grossmann RE, Zughaier SM, Liu S, Lyles RH, Tangpricha V. Impact of vitamin D supplementation on markers of inflammation in adults with cystic fibrosis hospitalized for a pulmonary exacerbation. Eur J Clin Nutr. 2012;66(9):1072–1074. doi:10.1038/ejcn.2012.82
   PubMed Web of Science ®Google Scholar
• Wei R, Christakos S. Mechanisms underlying the regulation of innate and adaptive immunity by vitamin D. Nutrients. 2015;7(10):8251–8260. doi:10.3390/nu7105392
   PubMed Web of Science ®Google Scholar
• Patrick RP, Ames BN. Vitamin D and the omega-3 fatty acids control serotonin synthesis and action, part 2: relevance for ADHD, bipolar disorder, schizophrenia, and impulsive behavior. FASEB J. 2015;29(6):2207–2222. doi:10.1096/fj.14-268342
   PubMed Web of Science ®Google Scholar
• Catena-Dell’Osso M, Bellantuono C, Consoli G, Baroni S, Rotella F, Marazziti D. Inflammatory and neurodegenerative pathways in depression: a new avenue for antidepressant development? Curr Med Chem. 2011;18(2):245–255. doi:10.2174/092986711794088353
   PubMed Web of Science ®Google Scholar
• Berk M, Williams LJ, Jacka FN, et al. So depression is an inflammatory disease, but where does the inflammation come from? BMC Med. 2013;11(1):1–16. doi:10.1186/1741-7015-11-200
   PubMed Web of Science ®Google Scholar
• Andreazza AC, Wang JF, Salmasi F, Shao L, Young LT. Specific subcellular changes in oxidative stress in prefrontal cortex from patients with bipolar disorder. J Neurochem. 2013;127(4):552–561. doi:10.1111/jnc.12316
   PubMed Web of Science ®Google Scholar
• Galior K, Grebe S, Singh R. Development of vitamin d toxicity from overcorrection of vitamin D deficiency: a review of case reports. Nutrients. 2018;10(8):953. doi:10.3390/nu10080953
   PubMed Web of Science ®Google Scholar
• Shahrokhi M, Nagalli S. Probiotics. In: StatPearls. StatPearls Publishing; 2021.
   Google Scholar
• Chao L, Liu C, Sutthawongwadee S, et al. Effects of probiotics on depressive or anxiety variables in healthy participants under stress conditions or with a depressive or anxiety diagnosis: a meta-analysis of randomized controlled trials. Front Neurol. 2020;11. doi:10.3389/fneur.2020.00421
   Web of Science ®Google Scholar
• Yong SJ, Tong T, Chew J, Lim WL. Antidepressive mechanisms of probiotics and their therapeutic potential. Front Neurosci. 2020;13. doi:10.3389/fnins.2019.01361
   PubMed Web of Science ®Google Scholar
• Louzada ER, Ribeiro SML. Synbiotic supplementation, systemic inflammation, and symptoms of brain disorders in elders: a secondary study from a randomized clinical trial. Nutr Neurosci. 2018;23(2):93–100. doi:10.1080/1028415X.2018.1477349
   PubMed Web of Science ®Google Scholar
• Nguyen PH, DiGirolamo AM, Gonzalez-Casanova I, et al. Impact of preconceptional micronutrient supplementation on maternal mental health during pregnancy and postpartum: results from a randomized controlled trial in Vietnam. BMC Womens Health. 2017;17(1):1–9. doi:10.1186/s12905-017-0401-3
   PubMed Web of Science ®Google Scholar
• Von Berens Å, Fielding RA, Gustafsson T, et al. Effect of exercise and nutritional supplementation on health-related quality of life and mood in older adults: the VIVE2 randomized controlled trial. BMC Geriatr. 2018;18(1):1–8. doi:10.1186/s12877-018-0976-z
   PubMed Web of Science ®Google Scholar
• Oliver-Baxter JM, Whitford HS, Turnbull DA, Bond MJ. Effects of vitamin supplementation on inflammatory markers and psychological wellbeing among distressed women: a randomized controlled trial. J Integr Med. 2018;16(5):322–328. doi:10.1016/j.joim.2018.06.001
   PubMed Web of Science ®Google Scholar
• Harris E, Kirk J, Rowsell R, et al. The effect of multivitamin supplementation on mood and stress in healthy older men. Hum Psychopharmacol Clin Exp. 2011;26(8):560–567. doi:10.1002/hup.1245
   PubMed Web of Science ®Google Scholar
• Jaremka L, Lindgren M, Kiecolt-Glaser J. Synergistic relationships among stress, depression, and troubled relationships: insights from psychoneuroimmunology. Depress Anxiety. 2013;30(4):1–15. doi:10.1002/da.22078
   PubMed Web of Science ®Google Scholar
• Harris E, Kirk J, Rowsell R, et al. A double-blind trial of bupropion versus desipramine for bipolar depression. Hum Psychopharmacol Clin Exp. 2011;26(8):560–567. doi:10.1002/hup.1245
   PubMed Web of Science ®Google Scholar
• Okronipa H, Adu-Afarwuah S, Lartey A, et al. Maternal supplementation with small-quantity lipid-based nutrient supplements during pregnancy and lactation does not reduce depressive symptoms at 6 months postpartum in Ghanaian women: a randomized controlled trial. Arch Womens Ment Health. 2018;21(1):55–63. doi:10.1007/s00737-017-0752-7
   PubMed Web of Science ®Google Scholar
• Sublette ME, Ellis SP, Geant AL, Mann JJ. NIH public access. J Clin Psychiatr. 2011;72(12):1577–1584. doi:10.4088/JCP.10m06634.Meta-analysis
   PubMed Web of Science ®Google Scholar
• Mazloom Z, Ekramzadeh M, Hejazi N. Efficacy of supplementary vitamins C and E on anxiety, depression and stress in type 2 diabetic patients: a randomized, single-blind, placebo-controlled trial. Pakistan J Biol Sci. 2013;16(22):1597–1600. doi:10.3923/pjbs.2013.1597.1600
   PubMedGoogle Scholar
• Vaucher P, Druais PL, Waldvogel S, Favrat B. Effect of iron supplementation on fatigue in nonanemic menstruating women with low ferritin: a randomized controlled trial. CMAJ. 2012;184(11):1247–1254. doi:10.1503/cmaj.110950
   PubMed Web of Science ®Google Scholar
• Jamilian H, Jamilian M, Samimi M, et al. Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial. Gynecol Endocrinol. 2017;33(6):442–447. doi:10.1080/09513590.2017.1290071
   PubMed Web of Science ®Google Scholar
• Sanoobar M, Dehghan P, Khalili M, Azimi A, Seifar F. Coenzyme Q10 as a treatment for fatigue and depression in multiple sclerosis patients: a double blind randomized clinical trial. Nutr Neurosci. 2015;19(3):138–143. doi:10.1179/1476830515Y.0000000002
   PubMed Web of Science ®Google Scholar
• Asadi S, Gholami MS, Siassi F, Qorbani M, Sotoudeh G. Beneficial effects of nano-curcumin supplement on depression and anxiety in diabetic patients with peripheral neuropathy: a randomized, double-blind, placebo-controlled clinical trial. Phyther Res. 2020;34(4):896–903. doi:10.1002/ptr.6571
   PubMed Web of Science ®Google Scholar
• Yu JJ, Pei LB, Zhang Y, Wen ZY, Yang JL. Chronic supplementation of curcumin enhances the efficacy of antidepressants in major depressive disorder. J Clin Psychopharmacol. 2015;35(4):406–410. doi:10.1097/JCP.0000000000000352
   PubMed Web of Science ®Google Scholar
• Rahimi HR, Nedaeinia R, Sepehri Shamloo A, Nikdoust S, Kazemi Oskuee R. Novel delivery system for natural products: nano-curcumin formulations. Avicenna J Phytomed. 2016;6(4):383–398.
   PubMed Web of Science ®Google Scholar
• Mohammed HS, Khadrawy YA, El-Sherbini TM, Amer HM. Electrocortical and biochemical evaluation of antidepressant efficacy of formulated nanocurcumin. Appl Biochem Biotechnol. 2019;187(3):1096–1112. doi:10.1007/s12010-018-2866-4
   PubMed Web of Science ®Google Scholar
• Ramaholimihaso T, Bouazzaoui F, Kaladjian A. Curcumin in depression: potential mechanisms of action and current evidence—a narrative review. Front Psychiatry. 2020;11:1–16. doi:10.3389/fpsyt.2020.572533
   PubMed Web of Science ®Google Scholar
• Fidelis EM, Savall ASP, da Luz Abreu E, et al. Curcumin-loaded nanocapsules reverses the depressant-like behavior and oxidative stress induced by β-amyloid in mice. Neuroscience. 2019;423:122–130. doi:10.1016/j.neuroscience.2019.09.032
   PubMed Web of Science ®Google Scholar
• Rajizadeh A, Mozaffari-Khosravi H, Yassini-Ardakani M, Dehghani A. Effect of magnesium supplementation on depression status in depressed patients with magnesium deficiency: a randomized, double-blind, placebo-controlled trial. Nutrition. 2017;35:56–60. doi:10.1016/j.nut.2016.10.014
   PubMed Web of Science ®Google Scholar
• Szewczyk B, Poleszak E, Sowa-Kuæma M, et al. Shear wave elastography of abdominal and retroperitoneal masses and inflammatory processes: a feasibility study. Ultrasound Med Biol. 2008;37(8):S33–S34. doi:10.1016/j.ultrasmedbio.2011.05.163
   Google Scholar
• Bavithra S, Sugantha Priya E, Selvakumar K, Krishnamoorthy G, Arunakaran J. Effect of melatonin on glutamate: BDNF signaling in the cerebral cortex of Polychlorinated Biphenyls (PCBs)—exposed adult male rats. Neurochem Res. 2015;40(9):1858–1869. doi:10.1007/s11064-015-1677-z
   PubMed Web of Science ®Google Scholar
• Tonon AC, Pilz LK, Markus RP, Hidalgo MP, Elisabetsky E. Melatonin and depression: a translational perspective from animal models to clinical studies. Front Psychiatr.2021;12:1–13. doi:10.3389/fpsyt.2021.638981
   Web of Science ®Google Scholar
• Jamilian H, Jamilian M, Foroozanfard F, Afshar Ebrahimi F, Bahmani F, Asemi Z. Comparison of myo-inositol and metformin on mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial. J Psychosom Obstet Gynecol. 2018;39(4):307–314. doi:10.1080/0167482X.2017.1383381
   PubMed Web of Science ®Google Scholar
• Hariri N, Darafshi Ghahroudi S, Jahangiri S, Borumandnia N, Narmaki E, Saidpour A. The beneficial effects of sumac (Rhus coriaria L.) supplementation along with restricted calorie diet on anthropometric indices, oxidative stress, and inflammation in overweight or obese women with depression: a randomized clinical trial. Phyther Res. 2020;34(11):3041–3051. doi:10.1002/ptr.6737
   PubMed Web of Science ®Google Scholar
• Shabbir A. Rhus coriaria Linn, a plant of medicinal, nutritional and industrial importance: a review. J Anim Plant Sci. 2012;22(2):505–512.
   Web of Science ®Google Scholar
• Rahideh ST, Shidfar F, Khandozi N, Rajab A, Hosseini SP, Mirtaher SM. The effect of sumac (Rhus coriaria L.) powder on insulin resistance, malondialdehyde, high sensitive C-reactive protein and paraoxonase 1 activity in type 2 diabetic patients. J Res Med Sci. 2014;19(10):933–938.
   PubMed Web of Science ®Google Scholar
• Bitarafan S, Saboor-yaraghi A, Sahraian M, Soltani D, Nafissi S. Effect of vitamin A supplementation on fatigue and depression in multiple sclerosis patients. Iran J Allergy Asthma Immunol. 2016;15:13–19.
   PubMed Web of Science ®Google Scholar
• Jafarirad S, Siassi F, Harirchian MH, et al. The effect of vitamin A supplementation on stimulated T-cell proliferation with myelin oligodendrocyte glycoprotein in patients with multiple sclerosis. J Neurosci Rural Pract. 2012;3(3):294–298. doi:10.4103/0976-3147.102609
   PubMedGoogle Scholar
• Sangle P, Sandhu O, Aftab Z, Anthony AT, Khan S. Vitamin B12 supplementation: preventing onset and improving prognosis of depression. Cureus. 2020;12(10):1–7. doi:10.7759/cureus.11169
   Web of Science ®Google Scholar
• Solati Z, Jazayeri S, Tehrani-Doost M, Mahmoodianfard S, Gohari MR. Zinc monotherapy increases serum brain derived neurotrophic factor (BDNF) levels and decreases depressive symptoms in overweight or obese subjects: a double-blind, randomized, placebo-controlled trial. Nutr Neurosci. 2015;18(4):162–168. doi:10.1179/1476830513Y.0000000105
   PubMed Web of Science ®Google Scholar
• Ranjbar E, Shams J, Sabetkasaei M, et al. Effects of zinc supplementation on efficacy of antidepressant therapy, inflammatory cytokines, and brain-derived neurotrophic factor in patients with major depression. Nutr Neurosci. 2014;17(2):65–71. doi:10.1179/1476830513y.0000000066
   PubMed Web of Science ®Google Scholar
• Paoletti P, Vergnano AM, Barbour B, Casado M. Zinc at glutamatergic synapses. Neuroscience. 2009;158(1):126–136. doi:10.1016/j.neuroscience.2008.01.061
   PubMed Web of Science ®Google Scholar
• Amr M, El-Mogy A, Shams T, Vieira K, Lakhan S. Efficacy of vitamin C as an adjunct to fluoxetine therapy in pediatric major depressive disorder. Clin Nutr. 2013;33–50. doi:10.1201/b16308-5
   Google Scholar
• Rice ME. Ascorbate regulation and its neuroprotective role in the brain. Trends Neurosci. 2000;23(5):209–216. doi:10.1016/S0166-2236(99)01543-X
   PubMed Web of Science ®Google Scholar
• Papakostas GI. Dopaminergic-based pharmacotherapies for depression. Eur Neuropsychopharmacol. 2006;16(6):391–402. doi:10.1016/j.euroneuro.2005.12.002
   PubMed Web of Science ®Google Scholar
• Gharekhani A, Khatami MR, Dashti-Khavidaki S, et al. The effect of omega-3 fatty acids on depressive symptoms and inflammatory markers in maintenance hemodialysis patients: a randomized, placebo-controlled clinical trial. Eur J Clin Pharmacol. 2014;70(6):655–665. doi:10.1007/s00228-014-1666-1
   PubMed Web of Science ®Google Scholar
• Keshavarz SA, Mostafavi SA, Akhondzadeh S, et al. Omega-3 supplementation effects on body weight and depression among dieter women with co-morbidity of depression and obesity compared with the placebo: a randomized clinical trial. Clin Nutr ESPEN. 2018;25:37–43. doi:10.1016/j.clnesp.2018.03.001
   PubMed Web of Science ®Google Scholar
• Rizzo AM, Corsetto PA, Montorfano G, et al. Comparison between the AA/EPA ratio in depressed and non depressed elderly females: omega-3 fatty acid supplementation correlates with improved symptoms but does not change immunological parameters. Nutr J. 2012;11(1):1–11. doi:10.1186/1475-2891-11-82
   PubMed Web of Science ®Google Scholar
• Jiang W, Whellan DJ, Adams KF, et al. Long-chain omega-3 fatty acid supplements in depressed heart failure patients: results of the OCEAN trial. JACC Hear Fail. 2018;6(10):833–843. doi:10.1016/j.jchf.2018.03.011
   PubMed Web of Science ®Google Scholar
• Vaz S, Farias DR, Rodrigues A, Adegboye A, Nardi AE, Kac G. Omega-3 supplementation from pregnancy to postpartum to prevent depressive symptoms: a randomized placebo- controlled trial. BMC Pregnancy Childbirth.2017;1–13. DOI:10.1186/s12884-017-1365-x
   PubMed Web of Science ®Google Scholar
• Antypa N, Smelt AHM, Strengholt A, Van Der Does AJW. Effects of omega-3 fatty acid supplementation on mood and emotional information processing in recovered depressed individuals. J Psychopharmacol. 2012;26(5):738–743. doi:10.1177/0269881111424928
   PubMed Web of Science ®Google Scholar
• Maltais M, de Souto Barreto P, Pothier K, et al. Lifestyle multidomain intervention, omega-3 supplementation, or both for reducing the risk of developing clinically relevant depressive symptoms in older adults with memory complaints? Secondary analysis from the MAPT trial. Exp Gerontol. 2019;120:28–34. doi:10.1016/j.exger.2019.02.010
   PubMed Web of Science ®Google Scholar
• Giltay E, Geleijnse J, Kromhout D. Effects of n 2 3 fatty acids on depressive symptoms and dispositional. Am J Clin Nutr. 2011;94(6):1442–1450. doi:10.3945/ajcn.111.018259.INTRODUCTION
   PubMed Web of Science ®Google Scholar
• Kuszewski JC, Howe PRC, Wong RHX. An exploratory analysis of changes in mental wellbeing following curcumin and fish oil supplementation in middle-aged and older adults. Nutrients. 2020;12(10):1–13. doi:10.3390/nu12102902
   Web of Science ®Google Scholar
• Meyer BJ, Grenyer BFS, Crowe T, Owen AJ, Grigonis-Deane EM, Howe PRC. Improvement of major depression is associated with increased erythrocyte DHA. Lipids. 2013;48(9):863–868. doi:10.1007/s11745-013-3801-7
   PubMed Web of Science ®Google Scholar
• Andreeva VA, Galan P, Torrès M, Julia C, Hercberg S, Kesse-Guyot E. Supplementation with B vitamins or N-3 fatty acids and depressive symptoms in cardiovascular disease survivors: ancillary findings from the SUpplementation with FOLate, vitamins B-6 and B-12 and/or OMega-3 fatty acids (SU.FOL.OM3) randomized trial. Am J Clin Nutr. 2012;96(1):208–214. doi:10.3945/ajcn.112.035253
   PubMed Web of Science ®Google Scholar
• Sepehrmanesh Z, Kolahdooz F, Abedi F, et al. Vitamin D supplementation affects the beck depression inventory, insulin resistance, and biomarkers of oxidative stress in patients with major depressive disorder: a randomized. J Nutr.2016;(5):1–6. doi:10.3945/jn.115.218883
   Web of Science ®Google Scholar
• Vaziri F, Nasiri S, Tavana Z, Dabbaghmanesh MH, Sharif F. A randomized controlled trial of vitamin D supplementation on perinatal depression: in Iranian pregnant mothers. BMC Pregnancy Childbirth. 2016;16:1–12. doi:10.1186/s12884-016-1024-7
   PubMed Web of Science ®Google Scholar
• Kjærgaard M, Waterloo K, Wang CEA, et al. Effect of vitamin D supplement on depression scores in people with low levels of serum 25-hydroxyvitamin D: nested case – control study and randomised clinical trial. Br J Psychiatry. 2012;25:360–368. doi:10.1192/bjp.bp.111.104349
   Web of Science ®Google Scholar
• Zheng S, Tu L, Cicuttini F, et al. Effect of vitamin D supplementation on depressive symptoms in patients with knee osteoarthritis. J Am Med Dir Assoc. 2018;20:1634–1640.e1. doi:10.1016/j.jamda.2018.09.006
   PubMed Web of Science ®Google Scholar
• Sharifi A, Vahedi H, Nedjat S. Vitamin D decreases beck depression inventory score in patients with mild to moderate ulcerative colitis: a double-blind randomized placebo- controlled trial vitamin D decreases beck depression inventory score in patients with mild to moderate ulcerative. J Diet Suppl. 2018;0211. DOI:10.1080/19390211.2018.1472168
   PubMed Web of Science ®Google Scholar
• Omidian M, Mahmoudi M, Abshirini M. Diabetes & metabolic syndrome: clinical research & reviews effects of vitamin D supplementation on depressive symptoms in type 2 diabetes mellitus patients: randomized placebo-controlled double- blind clinical trial. Diabetes Metab Syndr Clin Res Rev. 2019;13(4):2375–2380. doi:10.1016/j.dsx.2019.06.011
   PubMed Web of Science ®Google Scholar
• Alavi NM, Khademalhoseini S, Vakili Z, Assarian F. Effect of vitamin D supplementation on depression in elderly patients: a randomized clinical trial. Clin Nutr. 2018;38:2065–2070. doi:10.1016/j.clnu.2018.09.011
   PubMed Web of Science ®Google Scholar
• Hansen JP, Pareek M, Hvolby A, et al. Vitamin D3 supplementation and treatment outcomes in patients with depression (D3-vit-dep). BMC Res Notes. 2019;12(1):1–6. doi:10.1186/s13104-019-4218-z
   PubMed Web of Science ®Google Scholar
• Okereke OI, Iii CFR, Mischoulon D, et al. Effect of long-term vitamin D3 supplementation vs placebo on risk of depression or clinically relevant depressive symptoms and on change in mood scores: a randomized clinical trial. Jama. 2020;02114(5):471–480. DOI:10.1001/jama.2020.10224
   Web of Science ®Google Scholar
• De Koning EJ, Lips P, Heijboer AC, Den Heijer M, Bet PM, Van Schoor NM. Vitamin D supplementation for the prevention of depression and poor physical function in older persons: the D-Vitaal study, a randomized clinical trial. Am J Clin Nutr. 2019;110:1119–1130. doi:10.1093/ajcn/nqz141
   PubMed Web of Science ®Google Scholar
• Rolf L, Muris A, Bol Y, Smolders J, Smolders J, Hupperts R. Vitamin D3 supplementation and the IL-2/IL-2R pathway in multiple sclerosis: attenuation of progressive disturbances? J Neuroimmunol. 2017;314:50–57. doi:10.1016/j.jns.2017.04.017
   PubMed Web of Science ®Google Scholar
• Mousa A, Naderpoor N, De Courten MPJ, De Courten B. Vitamin D and symptoms of depression in overweight or obese adults: a cross-sectional study and randomized placebo-controlled trial. J Steroid Biochem Mol Biol. 2017. doi:10.1016/j.jsbmb.2017.08.002
   Web of Science ®Google Scholar
• Wang Y, Liu Y, Lian Y, Li N, Liu H, Li G. Efficacy of high-dose supplementation with oral vitamin D3 on depressive symptoms in dialysis patients with vitamin D3 insufficiency. Nan Fang Yi Ke da Xue Xue Bao. 2016;36(3):1–7. doi:10.1097/JCP.0000000000000486
   PubMedGoogle Scholar
• Moludi J, Alizadeh M, Mohammadzad MHS, Davari M. The effect of probiotic supplementation on depressive symptoms and quality of life in patients after myocardial infarction: results of a preliminary double-blind clinical trial. Psychosom Med. 2019;81(9):770–777. doi:10.1097/PSY.0000000000000749
   PubMed Web of Science ®Google Scholar
• Inoue T, Kobayashi Y, Mori N, et al. Effect of combined bifidobacteria supplementation and resistance training on cognitive function, body composition and bowel habits of healthy elderly subjects. Benef Microbes. 2018;9(6):843–853. doi:10.3920/BM2017.0193
   PubMed Web of Science ®Google Scholar
• Mohammadi AA, Jazayeri S, Khosravi-Darani K, et al. The effects of probiotics on mental health and hypothalamic–pituitary–adrenal axis: a randomized, double-blind, placebo-controlled trial in petrochemical workers. Nutr Neurosci. 2016;19(9):387–395. doi:10.1179/1476830515Y.0000000023
   PubMed Web of Science ®Google Scholar
• Kouchaki E, Tamtaji OR, Salami M, et al. Clinical and metabolic response to probiotic supplementation in patients with multiple sclerosis: a randomized, double-blind, placebo-controlled trial. Clin Nutr. 2017;36(5):1245–1249. doi:10.1016/j.clnu.2016.08.015
   PubMed Web of Science ®Google Scholar
• Akkasheh G, Kashani-Poor Z, Tajabadi-Ebrahimi M, et al. Clinical and metabolic response to probiotic administration in patients with major depressive disorder: a randomized, double-blind, placebo-controlled trial. Nutrition. 2016;32(3):315–320. doi:10.1016/j.nut.2015.09.003
   PubMed Web of Science ®Google Scholar
• Reininghaus EZ, Platzer M, Kohlhammer-Dohr A, et al. Provit: supplementary probiotic treatment and vitamin b7 in depression—a randomized controlled trial. Nutrients. 2020;12(11):1–17. doi:10.3390/nu12113422
   Web of Science ®Google Scholar
• Bot M, Brouwer IA, Roca M, et al. Effect of multinutrient supplementation and food-related behavioral activation therapy on prevention of major depressive disorder among overweight or obese adults with subsyndromal depressive symptoms: the MooDFOOD randomized clinical trial. JAMA. 2019;321(9):858–868. doi:10.1001/jama.2019.0556
   PubMed Web of Science ®Google Scholar
• Liu QS, Deng R, Fan Y, et al. Low dose of caffeine enhances the efficacy of antidepressants in major depressive disorder and the underlying neural substrates. Mol Nutr Food Res. 2017;61(8):1–43. doi:10.1002/mnfr.201600910
   Web of Science ®Google Scholar
• Shabani A, Foroozanfard F, Kavossian E, et al. Effects of melatonin administration on mental health parameters, metabolic and genetic profiles in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial. J Affect Disord. 2019;250(November2018):51–56. doi:10.1016/j.jad.2019.02.066
   PubMed Web of Science ®Google Scholar
• de Koning EJ, van der Zwaluw NL, van Wijngaarden JP, et al. Effects of two-year vitamin B12 and folic acid supplementation on depressive symptoms and quality of life in older adults with elevated homocysteine concentrations: additional results from the B-proof study, an RCT. Nutrients. 2016;8(11):748. doi:10.3390/nu8110748
   PubMed Web of Science ®Google Scholar
• Bochyńska A, Lipczyńska-ŁOjkowska W, Gugała-Iwaniuk M, et al. The effect of vitamin B supplementation on homocysteine metabolism and clinical state of patients with chronic epilepsy treated with carbamazepine and valproic acid. Seizure. 2012;21(4):276–281. doi:10.1016/j.seizure.2012.01.013
   PubMed Web of Science ®Google Scholar
• Loria-Kohen V, Gómez-Candela C, Palma-Milla S, Amador-Sastre B, Hernanz A, Bermejo LM. Estudio piloto sobre el efecto de la suplementación con ácido fólico en la mejor de los niveles de homocisteína, función cognitiva y estado depresivo en trastornos de la conducta alimentaria [A pilot study of folic acid supplementation for improving homocysteine levels, cognitive, and depressive status in eating disorders]. Nutr Hosp. 2013;28(3):807–815. Spanish. doi:10.3305/nh.2013.28.3.6335
   PubMed Web of Science ®Google Scholar
• National Institutes of Health. Omega-3 fatty acids; 2021. Available from: https://ods.od.nih.gov/factsheets/Omega3FattyAcids-HealthProfessional/#h8. Accessed April 10, 2022.
   Google Scholar
• Forester B, Zuo C, Ravichandran C, et al. Coenzyme Q10 effects on creatine kinase activity and mood in geriatric bipolar depression. J Geriatr Psychiatry Neurol. 2012;25(1):1–16. doi:10.1177/0891988712436688
   Web of Science ®Google Scholar
• National Institutes of Health. Nutrient recommendations: Dietary Reference Intakes (DRI); 2022. Available from: https://ods.od.nih.gov/HealthInformation/Dietary_Reference_Intakes.aspx. Accessed May 3, 2022.
   Google Scholar
• Centers for Disease Control and Prevention (CDC). Folic acid safety, interactions, and effects on other outcomes; 2017. Available from: https://www.cdc.gov/ncbddd/folicacid/faqs/faqs-safety.html. Accessed May 3, 2022.
   Google Scholar
• Institute of Medicine Panel on Micronutrients. Dietary reference intakes for vitamin A, vitamin K, arsenic, boron, chromium, copper, iodine, iron, manganese, molybdenum, nickel, silicon, vanadium, and zinc; 2021. Available from: https://www.ncbi.nlm.nih.gov/books/NBK222309/. Accessed May 3, 2022.
   Google Scholar